Why Salary Transparency Would Help Create Equal Work Environments
Your Cheddar hosts Kristen Scholer and Tim Stenovec discuss the biggest stories in business, the market, and personal finance.
It's that time of year to start thinking about planning a vacation, but you better think twice before paying for it with your credit card! Leanna Haakons, Founder of Black Hawk Financial, and Author of "Young, Fun and Financially Free" joins Your Cheddar to discuss how credit card debt can impact your life and where to find vacations for a discount.
The Career Contessa website recently launched The Salary Project, a database to compare salaries within your industry and receive a personalized salary review service. Lauren McGoodwin, Founder and CEO of Career Contessa joins Your Cheddar to discuss why she feels salary transparency would create an equal work environment.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
